Brennan A, Meng Y, Holmes J, Hill-McManus D, Meier PS. Potential benefits of minimum unit pricing for alcohol versus a ban on below cost selling in England 2014: modelling study. BMJ 2014; 349:g5452.
Connor J, Kydd R, Maclennan B, Shield K, Rehm J. 2017. Alcohol-attributable cancer deaths under 80 years of age in New Zealand.Drug Alcohol Rev 2017; 36(3):415-423.
Connor J, Kydd R, Shield K, Rehm J. The burden of disease and injury attributable to alcohol in New Zealanders under 80 years of age: marked disparities by ethnicity and sex. The New Zealand Medical Journal 2015; 128(1409):15-28.
National Health and Medical Research Council of the Australian Government. Australian Guidelines to Reduce Health Risks from Drinking Alcohol. Canberra: National Health and Medical Research Council; 2009. Retrieved from https://www.nhmrc.gov.au/guidelines-publications/ds10 [Accessed 9 November 2017].
Fitzpatrick JP, Latimer J, Olson HC, Carter M, Oscar J, Lucas BR, Doney R, Salter C, Try J, Hawkes G, Fitzpatrick E. Prevalence and profile of Neurodevelopment and Fetal Alcohol Spectrum Disorder (FASD) amongst Australian Aboriginal children living in remote communities. Research in Developmental Disabilities. 201;65:114-26.
May PA, Baete A, Russo J, Elliott AJ, Blankenship J, Kalberg WO, Buckley D, Brooks M, Hasken J, Abdul-Rahman O, Adam MP. Prevalence and characteristics of fetal alcohol spectrum disorders. Pediatrics. 2014;134(5):855-66.
Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. Journal of Developmental & Behavioral Pediatrics. 2004; 25(4):228-38.
Cook JL, Green CR, Lilley CM, Anderson SM, Baldwin ME, Chudley AE, Conry JL, LeBlanc N, Loock CA, Lutke J, Mallon BF. Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan. Canadian Medical Association Journal. 2016; 188(3):191-7.